These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Metabolomics as a key integrator for "omic" advancement of personalized medicine and future therapies. Eckhart AD; Beebe K; Milburn M Clin Transl Sci; 2012 Jun; 5(3):285-8. PubMed ID: 22686208 [TBL] [Abstract][Full Text] [Related]
43. Omic space: coordinate-based integration and analysis of genomic phenomic interactions. Toyoda T; Wada A Bioinformatics; 2004 Jul; 20(11):1759-65. PubMed ID: 15037505 [TBL] [Abstract][Full Text] [Related]
44. Metabolic Model-Based Integration of Microbiome Taxonomic and Metabolomic Profiles Elucidates Mechanistic Links between Ecological and Metabolic Variation. Noecker C; Eng A; Srinivasan S; Theriot CM; Young VB; Jansson JK; Fredricks DN; Borenstein E mSystems; 2016; 1(1):. PubMed ID: 27239563 [TBL] [Abstract][Full Text] [Related]
45. Integrating transcriptome and proteome profiling: Strategies and applications. Kumar D; Bansal G; Narang A; Basak T; Abbas T; Dash D Proteomics; 2016 Oct; 16(19):2533-2544. PubMed ID: 27343053 [TBL] [Abstract][Full Text] [Related]
47. Understanding genomic alterations in cancer genomes using an integrative network approach. Wang E Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571 [TBL] [Abstract][Full Text] [Related]
51. Multiplex methods provide effective integration of multi-omic data in genome-scale models. Angione C; Conway M; LiĆ³ P BMC Bioinformatics; 2016 Mar; 17 Suppl 4(Suppl 4):83. PubMed ID: 26961692 [TBL] [Abstract][Full Text] [Related]
52. The agony and ecstasy of "OMIC" technologies in drug development. Bilello JA Curr Mol Med; 2005 Feb; 5(1):39-52. PubMed ID: 15720269 [TBL] [Abstract][Full Text] [Related]
53. 'Omic' and hypothesis-driven research in the molecular pharmacology of cancer. Weinstein JN Curr Opin Pharmacol; 2002 Aug; 2(4):361-5. PubMed ID: 12127867 [TBL] [Abstract][Full Text] [Related]
54. Synthesizing Systems Biology Knowledge from Omics Using Genome-Scale Models. Dahal S; Yurkovich JT; Xu H; Palsson BO; Yang L Proteomics; 2020 Sep; 20(17-18):e1900282. PubMed ID: 32579720 [TBL] [Abstract][Full Text] [Related]
55. Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer. Chari R; Thu KL; Wilson IM; Lockwood WW; Lonergan KM; Coe BP; Malloff CA; Gazdar AF; Lam S; Garnis C; MacAulay CE; Alvarez CE; Lam WL Cancer Metastasis Rev; 2010 Mar; 29(1):73-93. PubMed ID: 20108112 [TBL] [Abstract][Full Text] [Related]
57. Systems Biology Approaches to Understanding the Human Immune System. Dhillon BK; Smith M; Baghela A; Lee AHY; Hancock REW Front Immunol; 2020; 11():1683. PubMed ID: 32849587 [TBL] [Abstract][Full Text] [Related]
58. PlasmoID: A P. falciparum protein information discovery tool. Rao A; Yeleswarapu SJ; Raghavendra G; Srinivasan R; Bulusu G In Silico Biol; 2009; 9(4):195-202. PubMed ID: 20109149 [TBL] [Abstract][Full Text] [Related]
59. Use of "omics" technologies to dissect neurologic disease. Tosto G; Reitz C Handb Clin Neurol; 2016; 138():91-106. PubMed ID: 27637954 [TBL] [Abstract][Full Text] [Related]
60. Comparative Transcriptomes and EVO-DEVO Studies Depending on Next Generation Sequencing. Liu T; Yu L; Liu L; Li H; Li Y Comput Math Methods Med; 2015; 2015():896176. PubMed ID: 26543497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]